According to Marksans Pharma, its subsidiary company, Relonchem, has received marketing authorization for...
The Indian pharmaceutical market climbed to a year-on-year growth of 8.4% in January 2025, finding its feet with the assistance of...
The pharmaceutical enterprises in India to expand their market beyond the United States, as Trump administration proposed a tariff of...
US biopharma Amgen is allocating USD 200 million this year for its new facility in the region and intends to make substantial investments in the upcoming years, stated CEO Robert Bradway on Monday.
According to a new report ‘Indian Surgical Landscape and Surgical Consumables Market’ by 1Lattice indicates that India’s healthcare sector is undergoing a significant transformation, as its surgical environment is rapidly changing due to a growing...
During intraday trading on Monday, GlaxoSmithKline Pharmaceuticals saw its share price shoot up by 5% to Rs 2,640 on the BSE, with a three-month high. The BSE Sensex dropped by...
Zydus Lifesciences, a global health care company focused solely on affordable medicines, has received final USFDA approval for Ibuprofen and Famotidine tablet
The chairman of Zydus Lifesciences, Pankaj R Patel, stated on Friday that the Indian pharmaceutical industry can produce 100 new drugs for global markets by 2047, supported by improved research and development initiatives...
Pharmaceutical industry Cipla has obtained final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) it submitted for ‘Nilotinib Capsules 50, 150, and 200 mg’...
On February 19, pharmaceutical stocks faced pressure after remarks from US President Donald Trump, indicating that the US could implement tariffs close to 25% on imports of pharmaceuticals, automobiles, and semiconductors...
, CDSCO.jpg)
